The therapeutic potential of BCP in DM and its complications could be ascribed to favorable modulation of all these proteins and molecular targets which play critical role in the pathophysiology of DM by impairing insulin signal transduction and altered glucose homeostasis. Here, INS is linked to diabetes mellitus.